Assignee
TIZIANA LIFE SCIENCES PLC
GB·4 granted patents·12 pending applications·8 citations·filing 2017–2025
Top patents by PatentIndex Score
16 records- 0194US10688186B2Anti-CD3 antibody formulationsTIZIANA LIFE SCIENCES PLC·Filed 2017·Granted Jun 23, 2020·7 cites·33 claims
- 0282US10973773B2Dactinomycin compositions and methods for the treatment of myelodysplastic syndrome and acute myeloid leukemiaTIZIANA LIFE SCIENCES PLC·Filed 2017·Granted Apr 13, 2021·1 cites·5 claims
- 0379US2024285632A1Formulations of milciclib and therapeutic combinations of the same for use in the treatment of cancerTIZIANA LIFE SCIENCES PLC·Filed 2023·Application pending·0 cites
- 0471US10758541B2Formulations of milciclib and therapeutic combinations of the same for use in the treatment of cancerTIZIANA LIFE SCIENCES PLC·Filed 2018·Granted Sep 1, 2020·0 cites·30 claims
- 0571US2025228946A1Anti-cd3 antibody formulationsTIZIANA LIFE SCIENCES PLC·Filed 2025·Application pending·0 cites
- 0668US11975111B2Dactinomycin compositions and methods for the treatment of myelodysplastic syndrome and acute myeloid leukemiaTIZIANA LIFE SCIENCES PLC·Filed 2021·Granted May 7, 2024·0 cites·5 claims
- 0765US2023365689A1Nasal formulations of foralumabTIZIANA LIFE SCIENCES PLC·Filed 2023·Application pending·0 cites
- 0865US2020390769A1Formulations of milciclib and therapeutic combinations of the same for use in the treatment of cancerTIZIANA LIFE SCIENCES PLC·Filed 2020·Application pending·0 cites
- 0964US2021000957A1Anti-cd3 antibody formulationsTIZIANA LIFE SCIENCES PLC·Filed 2020·Application pending·0 cites
- 1061US2024350497A1Combination therapy for the treatment of pan-kras mutated cancersTIZIANA LIFE SCIENCES PLC·Filed 2022·Application pending·0 cites
- 1161US2024425591A1Methods of suppressing microglial activationTIZIANA LIFE SCIENCES PLC·Filed 2022·Application pending·0 cites
- 1258US2022332822A1Subcutaneous administration of antibodies for the treatment of diseaseTIZIANA LIFE SCIENCES PLC·Filed 2022·Application pending·0 cites
- 1358US2021284743A1Compositions of il-6/il-6r antibodies and methods of use thereofTIZIANA LIFE SCIENCES PLC·Filed 2021·Application pending·0 cites
- 1457US2023227555A1Cd-3 antibodies for the treatment of coronavirusTIZIANA LIFE SCIENCES PLC·Filed 2021·Application pending·0 cites
- 1556US2023190804A1Compositions and methods for augmenting chimeric antigen receptor (car) t cell therapiesTIZIANA LIFE SCIENCES PLC·Filed 2021·Application pending·0 cites
- 1648US2022008533A1Composition and methods of treating inflammatory and autoimmune diseasesTIZIANA LIFE SCIENCES PLC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when TIZIANA LIFE SCIENCES PLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →